Please note: The University of Texas Health Science Center at San Antonio will now be called "UT Health San Antonio."

Filter by Program Categories

Dr. Michael Beckstead’s Featured In Parkinson’s News Today

← Previous entry Next entry →

Author: UTHSCSA Communications | Category: In The News | Physiology & Pharmacology | Physiology and Pharmacology | May 03, 2016

Graduate student Sarah Branch and Dr. Michael Beckstead's research on Parkinson's disease has been featured in Parkinson's News Today

Branch, the lead author in the study, worked on the project as part of her thesis. 

The team identified physiologic changes in dopamine neurons in a key animal model of Parkinson’s known to display disease symptoms, the MitoPark mouse model. 

“It’s a progressive model in that these changes don’t take place overnight,” Dr. Beckstead, the study’s senior author, said in a news release. “This makes it like the human disease, which is thought to be somewhere in the range of a 20-year process before symptoms become evident.”

The findings may lead to earlier identification of Parkinson’s in people and the start of disease treatments before irreparable damage is done.

They recently published a research paper  in The Journal of Neuroscience, called “Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson’s Disease.

“We don’t have any treatments right now that actually affect the disease process,” Dr. Beckstead said. “The reason we don’t have any is we don’t understand what’s going on in the early stages of this disease. Studies such as ours will help fill in those knowledge gaps.”

For the full article, click here

Copyright © 2019 The University of Texas Health Science Center at San Antonio

Links provided from the UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.

← Previous entry Next entry →

comments powered by Disqus